Richard Hurt

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Open doorway to truth: legacy of the Minnesota tobacco trial
    Richard D Hurt
    Division of Primary Care Internal Medicine, Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 84:446-56. 2009
  2. pmc Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    Arch Intern Med 172:1635-41. 2012
  3. doi Preventing lung cancer by treating tobacco dependence
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Clin Chest Med 32:645-57. 2011
  4. doi Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia
    Richard D Hurt
    Mayo Clinic Nicotine Dependence Research Program, 200 First Street SW, Rochester, MN 55905, USA
    Tob Control 21:306-12. 2012
  5. pmc Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional survey
    Jon O Ebbert
    Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Environ Health 6:28. 2007
  6. doi Treating tobacco dependence in a medical setting
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    CA Cancer J Clin 59:314-26. 2009
  7. pmc Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
    J Negat Results Biomed 10:1. 2011
  8. ncbi Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking
    Richard D Hurt
    Mayo Clinic and Mayo Foundation, Rochester, MN, USA
    J Clin Oncol 21:914-20. 2003
  9. ncbi Pharmacotherapy for alcoholic smokers
    Richard D Hurt
    Mayo Clinic, Nicotine Research Program, Rochester, Minnesota 55905, USA
    Alcohol Clin Exp Res 26:1939-41. 2002
  10. ncbi Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    J Matern Fetal Neonatal Med 17:281-9. 2005

Detail Information

Publications82

  1. pmc Open doorway to truth: legacy of the Minnesota tobacco trial
    Richard D Hurt
    Division of Primary Care Internal Medicine, Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 84:446-56. 2009
    ....
  2. pmc Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    Arch Intern Med 172:1635-41. 2012
    ..In 2002, a smoke-free restaurant ordinance was implemented in Olmsted County, Minnesota, and in 2007, all workplaces, including bars, became smoke free...
  3. doi Preventing lung cancer by treating tobacco dependence
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Clin Chest Med 32:645-57. 2011
    ..Treating tobacco dependence is one of the most cost-effective therapies in medicine and it deserves adequate reimbursement for it to be more widely available...
  4. doi Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia
    Richard D Hurt
    Mayo Clinic Nicotine Dependence Research Program, 200 First Street SW, Rochester, MN 55905, USA
    Tob Control 21:306-12. 2012
    ..Kreteks are clove/tobacco cigarettes that most Indonesians smoke...
  5. pmc Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional survey
    Jon O Ebbert
    Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Environ Health 6:28. 2007
    ..We undertook this study to evaluate the association between accumulated flight time in smoky airplane cabins and respiratory tract diseases in a cohort of never smoking flight attendants...
  6. doi Treating tobacco dependence in a medical setting
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    CA Cancer J Clin 59:314-26. 2009
    ..The effective treatment of tobacco dependence frequently requires tailoring, and often intensifying, interventions (both counseling and pharmacotherapy) to meet the needs of the individual patient...
  7. pmc Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
    J Negat Results Biomed 10:1. 2011
    ....
  8. ncbi Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking
    Richard D Hurt
    Mayo Clinic and Mayo Foundation, Rochester, MN, USA
    J Clin Oncol 21:914-20. 2003
    ..Participants and..
  9. ncbi Pharmacotherapy for alcoholic smokers
    Richard D Hurt
    Mayo Clinic, Nicotine Research Program, Rochester, Minnesota 55905, USA
    Alcohol Clin Exp Res 26:1939-41. 2002
  10. ncbi Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    J Matern Fetal Neonatal Med 17:281-9. 2005
    ..To determine the concentration of nicotine and cotinine in maternal blood and neonatal cord blood among pregnant Alaska Native women and to assess the neonates for neurobehavioral effects...
  11. ncbi Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome
    Richard D Hurt
    Nicotine Research Center, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Addict Behav 27:493-507. 2002
    ..These data should encourage others to perform similar pharmacologic relapse prevention studies with this or other pharmacotherapies...
  12. ncbi Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic College of Medicine, 200 First Street South West, Rochester, Minnesota 55905, USA
    J Stud Alcohol 66:506-16. 2005
    ....
  13. ncbi Preventing lung cancer by stopping smoking
    Richard D Hurt
    Nicotine Dependence Center, Division of Community Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Clin Chest Med 23:27-36, vii. 2002
    ..The use of these medications can be tailored to meet the patients needs and combinations of these medications can be used when appropriate. More intensive treatment, such as residential treatment, may be needed for more addicted smokers...
  14. ncbi New medications for nicotine dependence treatment
    R D Hurt
    Nicotine Dependence Center, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Nicotine Tob Res 1:S175-9; discussion S207-10. 1999
    ..3) What are the best combination treatments and which smokers are best suited for combination treatment? (4) Will other similar pharmacological agents with dopaminergic/noradrenergic activity have efficacy similar to bupropion?..
  15. ncbi Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels
    R D Hurt
    Nicotine Dependence Center, Division of Community Internal Medicine, Mayo Clinic, Rochester, Minn, USA
    Arch Pediatr Adolesc Med 154:31-7. 2000
    ..To determine the efficacy of nicotine patch therapy in adolescents who want to stop smoking and to assess biochemical markers of smoking and nicotine intake...
  16. ncbi Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening
    Cynthia O Townsend
    Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 103:2154-62. 2005
    ..Perhaps, recommendations from multiple cancer screenings may promote smoking abstinence among individuals at high risk for lung carcinoma...
  17. pmc Bupropion SR for the treatment of smokeless tobacco use
    Lowell C Dale
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Drug Alcohol Depend 90:56-63. 2007
    ..We conducted a multicenter, randomized, double-blind, placebo-controlled, clinical trial to assess the efficacy and safety of bupropion SR for tobacco abstinence among ST users...
  18. ncbi Change in smoking status after spiral chest computed tomography scan screening
    Lisa Sanderson Cox
    Nicotine Research Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 98:2495-501. 2003
    ..The current study evaluated smoking behavior changes in current and former smokers after low-dose, fast spiral chest computed tomography scan (CT) screening for lung carcinoma...
  19. pmc Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression
    Lisa Sanderson Cox
    Nicotine Dependence Center Research Program, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Gen Intern Med 19:828-34. 2004
    ..This study evaluated the efficacy of bupropion for relapse prevention in smokers with and without a past history of major depressive disorder. Changes in depressive symptoms were also examined...
  20. ncbi The effect of nicotine patch therapy on depression in nonsmokers: a preliminary study
    Lisa Sanderson Cox
    Nicotine Research Center, Mayo Clinic, Rochester, MN 55905, USA
    J Addict Dis 22:75-85. 2003
    ..Among the placebo participants, the mean HRSD score decreased (p = 0.038) by Day 2. The study needs replication with a larger sample and utilizing novel recruitment strategies...
  21. pmc A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics
    J Taylor Hays
    Department of Internal Medicine, Mayo Clinic College of Medicine, Mayo Clinic Nicotine Dependence Center, 200 1st Street Southwest, Rochester, MN 55905, USA
    Nicotine Tob Res 11:859-67. 2009
    ..We set out to investigate this issue further by conducting a randomized, double-blind, placebo-controlled trial of bupropion sustained-release (SR) for smoking relapse prevention among abstinent alcoholic smokers...
  22. doi Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study
    J Taylor Hays
    Mayo Clinic, Nicotine Dependence Center, Rochester, Minnesota 55905, USA
    J Subst Abuse Treat 40:102-7. 2011
    ..No serious adverse events were reported. Varenicline may be a useful aid for treating tobacco dependence among smokers who are in stable recovery from alcohol dependence. Further study of this treatment is warranted...
  23. ncbi Treating tobacco dependence: review of the best and latest treatment options
    Jon O Ebbert
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Thorac Oncol 2:249-56. 2007
    ..We review the currently available pharmacologic approaches to the treatment of tobacco dependence...
  24. ncbi Nicotine lozenges for the treatment of smokeless tobacco use
    Jon O Ebbert
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Nicotine Tob Res 9:233-40. 2007
    ..Future phase III clinical trials investigating the efficacy of nicotine lozenges are warranted...
  25. ncbi Expressive writing as a smoking cessation treatment adjunct for young adult smokers
    Steven C Ames
    Mayo Clinic Cancer Center, Jacksonville, FL 32224, USA
    Nicotine Tob Res 9:185-94. 2007
    ..Therefore, other modes of delivering expressive writing to young adult cigarette smokers should be explored...
  26. pmc Residential treatment compared with outpatient treatment for tobacco use and dependence
    J Taylor Hays
    Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:203-9. 2011
    ..To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice...
  27. doi Development and feasibility of a parental support intervention for adolescent smokers
    Steven C Ames
    Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida 32224, USA
    Subst Use Misuse 43:497-511. 2008
    ..This study expands on the knowledge of treating adolescent smokers and presents a new assessment measure. The study's limitations are noted. This investigation was funded by NICHHD...
  28. pmc Nicotine percentage replacement among smokeless tobacco users with nicotine patch
    Jon O Ebbert
    Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
    Drug Alcohol Depend 89:223-6. 2007
    ..We conclude that the use of 42 mg/day nicotine patch therapy is safe and should be considered as initial therapy in the clinical setting among ST users who use > or =3 cans/week...
  29. ncbi Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention
    Ivana T Croghan
    Nicotine Research Center, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:186-95. 2007
    ..To compare the combination of a nicotine inhaler and bupropion to either treatment alone for initiating smoking abstinence and relapse prevention...
  30. ncbi Validation of the revised Self-Administered Alcohol Screening Test (SAAST-R)
    Christi A Patten
    Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Addict 15:409-21. 2006
    ..The SAAST-R was found to have good sensitivity and specificity among both males and females...
  31. ncbi Second primary tumors following tobacco dependence treatments among head and neck cancer patients
    Yolanda I Garces
    Division of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Am J Clin Oncol 30:531-9. 2007
    ....
  32. pmc Combination pharmacotherapy for stopping smoking: what advantages does it offer?
    Jon O Ebbert
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Drugs 70:643-50. 2010
    ..Available data suggests that combination therapy may increase abstinence rates compared with monotherapy. However, the cost effectiveness of this approach has not been clearly demonstrated...
  33. ncbi Cough following initiation of smoking abstinence
    David O Warner
    Mayo Clinic, Rochester, MN 55905, USA
    Nicotine Tob Res 9:1207-12. 2007
    ..We conclude that an initial increase in cough is unlikely to occur among relatively healthy smokers who stop smoking and that changes in cough do not represent a barrier to maintaining abstinence for most smokers...
  34. pmc Feasibility of an exercise counseling intervention for depressed women smokers
    Kristin S Vickers
    Department of Psychiatry and Psychology, Mayo Clinic Rochester, 200 First Street South West, Rochester, MN 55905, USA
    Nicotine Tob Res 11:985-95. 2009
    ..This pilot study investigated the feasibility of an exercise intervention for depressed female smokers (Center for Epidemiological Studies Depression Scale [CES-D] score > or =16)...
  35. doi Combination treatment with varenicline and nicotine replacement therapy
    Jon O Ebbert
    Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
    Nicotine Tob Res 11:572-6. 2009
    ..A paucity of data exists regarding the safety and effectiveness of combination treatment with varenicline and nicotine replacement therapy (NRT)...
  36. doi Varenicline and bupropion sustained-release combination therapy for smoking cessation
    Jon O Ebbert
    Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
    Nicotine Tob Res 11:234-9. 2009
    ..Combination pharmacotherapy with these agents may increase long-term smoking abstinence rates above what is observed with single-agent therapy...
  37. doi The role of smoking in breast cancer development: an analysis of a Mayo Clinic cohort
    Ivana T Croghan
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Breast J 15:489-95. 2009
    ..81, p < 0.001). In this referral practice having a personal history of smoking is predictive of breast cancer diagnosis. Further studies are needed to further explore this relationship...
  38. pmc Waking a sleeping giant: the tobacco industry's response to the polonium-210 issue
    Monique E Muggli
    Nicotine Research Program, Mayo Clinic, Rochester, MN 55905, USA
    Am J Public Health 98:1643-50. 2008
    ..Tobacco companies continue to minimize their knowledge about polonium-210 in cigarettes in smoking and health litigation. Cigarette packs should carry a radiation-exposure warning label...
  39. doi Changes in readiness to quit and self-efficacy among adolescents receiving a brief office intervention for smoking cessation
    Christi A Patten
    Department of Psychiatry and Psychology and the Behavioral Health Research Program, Mayo Clinic College of Medicine, Rochester, MN, USA
    Psychol Health Med 13:326-36. 2008
    ..To examine changes in readiness to quit and self-efficacy among adolescents who received a clinic-based, brief office intervention (BOI) for smoking cessation...
  40. doi Change in perceived stress, partner support, decisional balance, and self-efficacy following residential nicotine dependence treatment
    Steven C Ames
    Mayo Clinic, Division of Hematology and Oncology, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    J Addict Dis 27:73-82. 2008
    ..This study provides new information about how residential treatment impacts psychosocial factors considered to be important predictors of tobacco abstinence in outpatient settings...
  41. pmc "Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China
    Monique E Muggli
    Mayo Clinic, Rochester, Minnesota, USA
    PLoS Med 5:1729-69. 2008
    ..Internal tobacco industry documents show that transnational tobacco companies (TTCs) have pursued a multifaceted strategy for undermining the adoption of restrictions on smoking in many countries...
  42. pmc Tobacco use and cessation among pregnant Alaska Natives from Western Alaska enrolled in the WIC program, 2001-2002
    Christi A Patten
    Mayo Clinic College of Medicine, Mayo Clinic Cancer Center, Charlton 6 273, 200 First Street SW, Rochester, MN 55905, USA
    Matern Child Health J 12:30-6. 2008
    ....
  43. ncbi Focus groups of Alaska Native adolescent tobacco users: preferences for tobacco cessation interventions and barriers to participation
    Christi A Patten
    Mayo Clinic College of Medicine, Rochester, Minnesota 55901, USA
    Health Educ Behav 36:711-23. 2009
    ..Parents were perceived as potentially supportive to the adolescent in quitting tobacco. The findings will be used to develop tobacco cessation programs for Alaska Native youth...
  44. ncbi Randomized clinical trial of an Internet-based versus brief office intervention for adolescent smoking cessation
    Christi A Patten
    Mayo Clinic College of Medicine, Department of Psychiatry and Psychology, Rochester, MN 55905, USA
    Patient Educ Couns 64:249-58. 2006
    ..Evaluation of novel treatment delivery methods, such as the Internet are notably absent from the adolescent smoking treatment literature...
  45. ncbi A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease)
    Leslie T Cooper
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Angiology 57:73-8. 2006
    ..03). In contrast to case reports of extreme tobacco dependence in the TAO population, the degree of tobacco dependence in subjects with TAO is similar to that in subjects with CAD...
  46. pmc A cigarette manufacturer and a managed care company collaborate to censor health information targeted at employees
    Monique E Muggli
    Nicotine Research Program, Mayo Clinic, St Paul, MN 55905, USA
    Am J Public Health 94:1307-11. 2004
    ..We recommend that accrediting bodies mandate that health plans not censor employee-directed health information at the request of employers...
  47. ncbi Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysis
    Yolanda I Garces
    Department of Oncology, Division of Radiation Oncology, Mayo Clinic, Charlton Building, Desk R, 200 First Street SW, Rochester, MN 55905, USA
    Cancer 101:116-24. 2004
    ..The current study described tobacco use outcomes among patients with head and neck carcinoma who underwent treatment for nicotine dependence at the Mayo Clinic Nicotine Dependence Center (NDC; Rochester, MN)...
  48. ncbi Residential treatment for smokeless tobacco use: a case series
    Jon O Ebbert
    Nicotine Dependence Center, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
    J Subst Abuse Treat 26:261-7. 2004
    ..More research is needed to replicate our findings and determine if comparable abstinence rates can be achieved with outpatient ST treatment programs using similar behavioral and pharmacotherapies...
  49. ncbi Training support persons to help smokers quit: a pilot study
    Christi A Patten
    Nicotine Research Program, Departmetn of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Prev Med 26:386-90. 2004
    ..Evaluate the feasibility, acceptability, and potential efficacy of a skills-training intervention for adults interested in helping someone to stop smoking (i.e., support persons)...
  50. ncbi Effectiveness of smoking cessation self-help materials in a lung cancer screening population
    Matthew M Clark
    Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA
    Lung Cancer 44:13-21. 2004
    ..Clearly, more investigation is warranted into how to tailor smoking interventions for cancer screening participants...
  51. ncbi Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users
    Jon O Ebbert
    Department of Internal Medicine, Division of Community Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Addict Behav 29:349-55. 2004
    ....
  52. ncbi Depressed versus nondepressed young adult tobacco users: differences in coping style, weight concerns and exercise level
    Kristin S Vickers
    Mayo Clinic, Nicotine Research Program, Section of Patient Education, Rochester, MN 55905, USA
    Health Psychol 22:498-503. 2003
    ..Multivariate logistic regression analysis indicated that higher maladaptive coping and lower level of exercise were significantly associated with depression among tobacco users...
  53. ncbi Differences in adolescent smoker and nonsmoker perceptions of strategies that would help an adolescent quit smoking
    Christi A Patten
    Mayo Clinic, Rochester, MN 55905, USA
    Ann Behav Med 26:124-33. 2003
    ..The results have implications for the design of peer-based and other interventions for adolescent smokers...
  54. ncbi Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependence
    Jennifer A Ferguson
    Section of Biostatistics, Mayo Clinic and Mayo Foundation, 200 First Street SW, Colonial 3, Rochester, MN 55905, USA
    Addict Behav 28:1203-18. 2003
    ..Assessment of these variables may be useful clinically by assisting health care providers in tailoring nicotine dependence interventions to enhance outcomes...
  55. ncbi Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting
    Gary A Croghan
    Mayo Clinic and Mayo Foundation Rochester MN 55905, USA
    Nicotine Tob Res 5:181-7. 2003
    ..Combination nicotine nasal spray and nicotine patches were delivered safely in a nonspecialized outpatient clinical setting and enhanced short-term smoking abstinence rates, but these rates were not sustained at 6 months...
  56. ncbi Treatment of tobacco dependence in alcoholics
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Recent Dev Alcohol 16:335-59. 2003
    ..However, the efficacy of several pharmacologic therapies for alcoholic smokers needs to be tested. In addition, further research is needed on effective treatments for recovering alcoholics of various racial/ethnic backgrounds...
  57. ncbi Relationship of tobacco use to depressive disorders and suicidality among patients treated for alcohol dependence
    Christi A Patten
    Nicotine Research Center, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA
    Am J Addict 12:71-83. 2003
    ..Tobacco use status was unrelated to a DD diagnosis after discharge from the IAP and was not associated with SA...
  58. ncbi Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study
    Lowell C Dale
    Division of Community Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Nicotine Tob Res 4:267-74. 2002
    ..2 +/- 5.0 kg in the placebo group (p = 0.49). Bupropion may increase abstinence rates in ST users and appears to attenuate weight gain during ST abstinence. Larger randomized, controlled trials of bupropion for ST users are needed...
  59. ncbi Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles
    Thomas P Moyer
    Drug Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA
    Clin Chem 48:1460-71. 2002
    ..Absence of nicotine metabolites and anabasine can be used to document abstinence from tobacco products, an indicator of treatment success...
  60. ncbi Weight concerns among male smokers
    Matthew M Clark
    Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
    Addict Behav 29:1637-41. 2004
    ..Motivation to quit smoking was found to be significantly lower in those with weight concerns (P < .001). Further investigation is needed to enable the tailoring of interventions for weight-concerned male smokers...
  61. ncbi Expressive writing intervention for young adult cigarette smokers
    Steven C Ames
    Mayo Clinic, Division of Hematology and Oncology, Jacksonville, Florida 32224, USA
    J Clin Psychol 61:1555-70. 2005
    ..Participants stated they benefited most from the support and structure associated with the brief office intervention. Enthusiasm was lacking for the expressive writing treatment adjunct...
  62. ncbi The prevalence of weight concerns in a smoking abstinence clinical trial
    Matthew M Clark
    Mayo Clinic Mayo Building W11, 200 First Street, SW, Rochester, MN 55905, USA
    Addict Behav 31:1144-52. 2006
    ..Additionally, being weight concerned may impact the short-term success rates of stopping smoking using pharmacotherapy...
  63. ncbi Personality correlates related to tobacco abstinence following treatment
    W Michael Hooten
    Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Int J Psychiatry Med 35:59-74. 2005
    ..The five-factor model of personality was used to describe the correlates of smoking abstinence...
  64. ncbi Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users
    Jon O Ebbert
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Nicotine Tob Res 9:43-52. 2007
    ..High-dose nicotine patch therapy is safe and well tolerated in this population of tobacco users...
  65. ncbi Revision of the Self-Administered Alcoholism Screening Test (SAAST-R): a pilot study
    Kristin S Vickers-Douglas
    Nicotine Dependence Center, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Subst Use Misuse 40:789-812. 2005
    ..Areas for refinement in the format and items of the SAAST-R were identified and suggestions for further validation studies are presented...
  66. pmc Blowing smoke: British American Tobacco's air filtration scheme
    Nadine Rae Leavell
    Mayo Clinic Nicotine Research Program, Rochester, MN 55905, USA
    BMJ 332:227-9. 2006
  67. ncbi Body image treatment for weight concerned smokers: a pilot study
    Matthew M Clark
    Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
    Addict Behav 30:1236-40. 2005
    ..At week 12, 7(35%) of the body image participants had 7-day point prevalence smoking abstinence, compared to 5(24%) of the participants in the weight management group (p=0.505)...
  68. doi Legislating tolerance: Spain's national public smoking law
    Monique E Muggli
    Mayo Clinic Nicotine Research Program, 127 Orlin Ave SE, Rochester, MN 55414, USA
    Tob Control 19:24-30. 2010
    ..In doing so, Spain's smoke-free public places law would be better aligned with the Framework Convention on Tobacco Control...
  69. ncbi Is smoking related to body image satisfaction, stress, and self-esteem in young adults?
    Ivana T Croghan
    Nicotine Dependence Program, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Health Behav 30:322-33. 2006
    ..To examine the association of smoking and gender with body image satisfaction, perceived stress, and self-esteem in young adults...
  70. ncbi Tobacco use during pregnancy among Alaska Natives in western Alaska
    Caroline C Renner
    Alaska Native Tribal Health Consortium, Office of Alaska Native Health Research, 4201 Tudor Centre Drive, Suite 105, Anchorage, AK 99508, USA
    Alaska Med 47:12-6. 2005
    ..To determine tobacco use rates during pregnancy among Alaska Natives residing on the Yukon-Kuskokwim (Y-K) Delta of western Alaska. Alaska Natives residing in this region use Iqmik, a unique form of smokeless tobacco (ST)...
  71. ncbi Characteristics of six-month tobacco use outcomes of Black patients seeking smoking cessation intervention
    Anita F Fernander
    Department of Behavioral Science, College of Medicine, University of Kentucky, USA
    J Health Care Poor Underserved 17:413-24. 2006
    ..I. 22% to 37%). An individualized nicotine dependence intervention conducted in an academic medical setting yielded encouraging abstinence rates for Black smokers...
  72. ncbi Tobacco use outcomes among patients with lung cancer treated for nicotine dependence
    Lisa Sanderson Cox
    Nicotine Research Center, Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Clin Oncol 20:3461-9. 2002
    ..This retrospective study examined the 6-month tobacco abstinence rate among lung cancer patients treated clinically for nicotine dependence...
  73. ncbi Effects of gender on relapse prevention in smokers treated with bupropion SR
    David Gonzales
    Department of Medicine, Oregon Health and Science University, Portland 97201, USA
    Am J Prev Med 22:234-9. 2002
    ..Lower abstinence and higher relapse rates are often reported for women treated with NRT. Gender effects for those treated with non-nicotinic, bupropion-hydrochloride sustained release for relapse prevention have not been studied...
  74. ncbi Iqmik: a form of smokeless tobacco used among Alaska natives
    Caroline C Renner
    Office of Alaska Native Health Research, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Am J Health Behav 29:588-94. 2005
    ..To describe a homemade form of smokeless tobacco known as Iqmik used among Alaska Natives residing in western Alaska...
  75. ncbi Tobacco and other substance use among Alaska Native youth in western Alaska
    Sarah Angstman
    Department of Psychology, University of Montana, Missoula, MT, USA
    Am J Health Behav 31:249-60. 2007
    ..To examine tobacco, alcohol, and other drug use rates among Alaska Native youth from western Alaska...
  76. ncbi Focus groups of Y-K Delta Alaska Natives: attitudes toward tobacco use and tobacco dependence interventions
    Caroline C Renner
    Yukon Kuskokwim Health Corporation, Bethel, AK, USA
    Prev Med 38:421-31. 2004
    ..This study employed focus group methodology to explore attitudes toward tobacco use and tobacco dependence interventions among Alaska Natives residing on the Y-K Delta...
  77. doi Urinary tobacco alkaloid measurement in patients having thromboangiitis obliterans
    Richard D Hurt
    Mayo Clin Proc 83:1187-8; author reply 1188. 2008
  78. ncbi Nicotine dependence treatment: perceived health status improvement with 1-year continuous smoking abstinence
    Ivana T Croghan
    Nicotine Research Program, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Eur J Public Health 15:251-5. 2005
    ....
  79. ncbi Exploring the association of John Henry active coping and education on smoking behavior and nicotine dependence among Blacks in the USA
    Anita F Fernander
    Department of Behavioral Science, College of Medicine, 103 College of Medicine Office Building, University of Kentucky, Lexington, KY 40536, USA
    Soc Sci Med 60:491-500. 2005
    ....
  80. ncbi Science for hire: a tobacco industry strategy to influence public opinion on secondhand smoke
    Monique E Muggli
    Nicotine Tob Res 5:303-14. 2003
    ..We suggest heightened monitoring of industry-created scientific organizations, further tobacco document research, and wide dissemination of such work...
  81. ncbi Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke
    Monique E Muggli
    Tobacco Document Consultancy, St Paul, MN 55105, USA
    Prev Med 39:568-80. 2004
    ....
  82. ncbi A race to the death: British American Tobacco and the Chinese Grand Prix
    Jeff Collin
    Centre on Global Change and Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
    Lancet 364:1107-8. 2004

Research Grants13

  1. Efficacy of Methylphenidate for treating tobacco dependence
    Richard Hurt; Fiscal Year: 2007
    ..If the results from this preliminary study support the performance of a larger clinical trial, then a future grant application will be submitted through the R01 research project grant mechanism. ..
  2. Tobacco Industry Documents on ETS-The Next Front
    Richard Hurt; Fiscal Year: 2007
    ....
  3. Tobacco Industry Documents on ETS-The Next Front
    Richard Hurt; Fiscal Year: 2004
    ..abstract_text> ..
  4. BUPROPION AND BEHAVIORAL TREATMENT FOR YOUNGER SMOKERS
    Richard Hurt; Fiscal Year: 2002
    ..Primary assessments will be point prevalence smoking abstinence rates at end of treatment (week 12) and at 52 weeks. ..